NO975838L - Melatoninagonister for behandling av godartet prostatisk hyperplasi - Google Patents

Melatoninagonister for behandling av godartet prostatisk hyperplasi

Info

Publication number
NO975838L
NO975838L NO975838A NO975838A NO975838L NO 975838 L NO975838 L NO 975838L NO 975838 A NO975838 A NO 975838A NO 975838 A NO975838 A NO 975838A NO 975838 L NO975838 L NO 975838L
Authority
NO
Norway
Prior art keywords
benign prostatic
prostatic hyperplasia
treatment
melatonin agonists
agonists
Prior art date
Application number
NO975838A
Other languages
English (en)
Other versions
NO975838D0 (no
Inventor
David O Clarke
William H Jordan
Lisa A Shipley
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO975838D0 publication Critical patent/NO975838D0/no
Publication of NO975838L publication Critical patent/NO975838L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)

Abstract

Foreliggende opprinnelse skaffer tilveie en fremgangsmåte for behandling av godartet prostatisk hyperplasi ved å anvende forskjellige melatoninagonister.
NO975838A 1995-06-14 1997-12-11 Melatoninagonister for behandling av godartet prostatisk hyperplasi NO975838L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20395P 1995-06-14 1995-06-14
PCT/US1996/010135 WO1997000069A1 (en) 1995-06-14 1996-06-12 Melatonin agonists for treating benign prostatic hyperplasia

Publications (2)

Publication Number Publication Date
NO975838D0 NO975838D0 (no) 1997-12-11
NO975838L true NO975838L (no) 1998-01-12

Family

ID=21690383

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975838A NO975838L (no) 1995-06-14 1997-12-11 Melatoninagonister for behandling av godartet prostatisk hyperplasi

Country Status (17)

Country Link
US (1) US5770610A (no)
EP (1) EP0748627A3 (no)
JP (1) JPH11507671A (no)
KR (1) KR19990022917A (no)
CN (1) CN1191484A (no)
AU (1) AU719501B2 (no)
BR (1) BR9608912A (no)
CA (1) CA2224649A1 (no)
CZ (1) CZ400597A3 (no)
EA (1) EA000946B1 (no)
HU (1) HUP9901139A3 (no)
IL (1) IL122316A0 (no)
NO (1) NO975838L (no)
NZ (1) NZ310852A (no)
PL (1) PL324172A1 (no)
TR (1) TR199701613T1 (no)
WO (1) WO1997000069A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL144900A (en) 2001-08-14 2013-12-31 Neurim Pharma 1991 Melatonin and drugs containing it for use in the treatment of primary insomnia, and the manufacture of those drugs
KR101041075B1 (ko) 2004-11-11 2011-06-13 삼성전자주식회사 광픽업 장치
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3105850A1 (de) * 1981-02-18 1982-08-19 Horst, Hans Jörg, Priv.Doz.Dr., 2057 Reinbek Mittel zum behandeln von tumoren
US4600723A (en) * 1983-05-18 1986-07-15 Monash University Method for minimizing disturbances in circadian rhythms of bodily performance and function
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors
DE3867957D1 (de) * 1987-08-05 1992-03-05 Daikin Ind Ltd Modifiziertes polytetrafluoraethylen und verfahren zu seiner herstellung.
US5242941A (en) * 1990-12-04 1993-09-07 State Of Oregon Methods of treating circadian rhythm disorders
IT222859Z2 (it) * 1991-08-01 1995-05-08 Bartolomeo Assenza Complesso osteointegrato costituito da un perno e da un collare intercambiabile avente l'altezza scelta in base allo spessore dello strato mucoso connettivale epiteliale del paziente
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
DE69303919T2 (de) * 1992-04-07 1997-01-30 Neurim Pharma 1991 Verwendung von Melatonin zur Herstellung eines Arzneimittels zur Behandlung der gutartigen Prostatahyperplasie
US6180657B1 (en) * 1993-11-18 2001-01-30 Eli Lilly And Company Melatonin derivatives for use in treating desynchronization disorders
US5654325A (en) * 1993-11-18 1997-08-05 Eli Lilly And Company Melatonin derivatives for use in treating sleep disorders
GB9407919D0 (en) * 1994-04-21 1994-06-15 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CN1191484A (zh) 1998-08-26
EA000946B1 (ru) 2000-06-26
IL122316A0 (en) 1998-04-05
HUP9901139A3 (en) 2000-01-28
EP0748627A2 (en) 1996-12-18
TR199701613T1 (xx) 1998-04-21
HUP9901139A2 (hu) 1999-08-30
NO975838D0 (no) 1997-12-11
WO1997000069A1 (en) 1997-01-03
EA199800058A1 (ru) 1998-08-27
US5770610A (en) 1998-06-23
PL324172A1 (en) 1998-05-11
AU719501B2 (en) 2000-05-11
CA2224649A1 (en) 1997-01-03
KR19990022917A (ko) 1999-03-25
BR9608912A (pt) 1999-03-02
AU6172896A (en) 1997-01-15
JPH11507671A (ja) 1999-07-06
EP0748627A3 (en) 1997-05-21
CZ400597A3 (cs) 1998-07-15
NZ310852A (en) 2000-07-28

Similar Documents

Publication Publication Date Title
EA200000220A1 (ru) Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
NO976078D0 (no) Fremgangsmåte for å behandle godartet prostatisk hyperplasi med varmeterapi
EP0667769A4 (en) USE OF SPECIFIC ALPHA-1C COMPOUNDS IN THE TREATMENT OF BENIGN PROSTATE HYPERPLASIA.
PT1203770E (pt) Piran -2-onas e 5, 6-di-hidropiran-2-onas uteis para o tratamento de hiperplasia e outras doencas
CA2163904A1 (en) Use of Indolocarbazole Derivatives to Treat a Pathological Condition of the Prostate
NO993396L (no) Kinolin- og kinolinforbindelser nyttige i terapi, spesielt i behandlingen av benign prostatisk hyperplasi
MY112949A (en) Benzo-thiaphene estrogen agonists to treat prostatic hyperplasia
AU3011299A (en) Combination therapy for the treatment of benign prostatic hyperplasia
EP0646007A4 (no)
ZA952763B (en) Use of alpha-1C specific compounds to treat benign prostatic hyperplasia
ATE211921T1 (de) Verwendung von gonadotropin zur behandlung der gestartigen hypertrophie der prostata
WO2003090753A8 (en) Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
NO975838L (no) Melatoninagonister for behandling av godartet prostatisk hyperplasi
NO982582L (no) Fremgangsmaate for behandling av smerte
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
KR950700746A (ko) 양성 전립선 비대를 치료하는 조성물 및 방법(Compositions and Methods For Treating Benign Prostatic Hypertrophy)
MX9710075A (es) Antagonistas melatonina para el tratamiento en la hiperplasia prostatica benigna.
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
AUPO410796A0 (en) Method of treating benign prostatic hyperplasia
ZA922010B (en) Improved method of treatment for benign prostatic hyperplasia
IT1265237B1 (it) Derivati basici dell'indolo
UA30521A (uk) Спосіб лікування доброякісної гіперплазії передміхурової залози у поєднанні з хронічним калькульозним простатитом

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application